(Q34087426)

30 July 2017

1 reference

title

Current viral risks of blood and blood products (English)

1 reference

30 July 2017

Dodd RY

1

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

32

1 reference

30 July 2017

issue

7

1 reference

30 July 2017

page(s)

469-474

1 reference

Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV-1 antibody screening. The Transfusion Safety Study Group

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07853890009002022

Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890009002022

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890009002022

Antibodies Reactive with Human T-Lymphotropic Retroviruses (HTLV-III) in the Serum of Patients with AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890009002022

Prevalence of HTLV-III antibody in American blood donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890009002022

Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. The HIV Seroconversion Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890009002022

Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890009002022

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890009002022

Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890009002022

Exposure of patients to human immunodeficiency virus through the transfusion of blood components that test antibody-negative

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890009002022

Evaluation of screened blood donations for human immunodeficiency virus type 1 infection by culture and DNA amplification of pooled cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890009002022

Transmission of retroviruses from seronegative donors by transfusion during cardiac surgery. A multicenter study of HIV-1 and HTLV-I/II infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890009002022

Seroprevalence and epidemiological correlates of HTLV-I infection in U.S. blood donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890009002022

The Declining Risk of Post-Transfusion Hepatitis C Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890009002022

Post-Transfusion Hepatitis C Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890009002022

Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890009002022

The transfusion-associated transmission of parvovirus B19.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890009002022

Posttransfusion Hepatitis Type A

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890009002022

10.3109/07853890009002022

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference